Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15,881Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Ethypharm

02 1Octavius Pharma Pvt. Ltd

03 5Pharmathen SA

04 1Anwita Drugs

05 2Apotex Inc

06 1Azurity Pharma

07 2Dorsa Darou Pharmaceutical Company

08 3Eurolab

09 3GLENMARK SPECLT

10 2Heron Therapeutics

11 3KMS Health Center

12 1Loxim Industries

13 4MERCK CANADA INC

14 1MSD INTL GMBH

15 1MYLAN PHARMACEUTICALS INC

16 20Merck & Co

17 1Murli Krishna Pharma

18 2Pantson Pharma Pvt. Limited

19 1Sakar Healthcare

20 3Sandoz B2B

21 2Southern Cross Pharma

22 3Torrent Pharmaceuticals Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEthypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Regulatory Info :

Registration Country : France

Aprepitant

Brand Name :

Dosage Form : Capsule

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : France

Ethypharm

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Regulatory Info :

Registration Country : India

Aprepitant

Brand Name : Aprepitant

Dosage Form : Pellets/Micro pellets for capsules

Dosage Strength : 40%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

03

arrow
Immuno-Oncology 360
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Aprepitant

Brand Name :

Dosage Form : Hard Capsule

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEthypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Regulatory Info :

Registration Country : France

Aprepitant

Brand Name :

Dosage Form : Capsule

Dosage Strength : 125MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : France

Ethypharm

05

arrow
Immuno-Oncology 360
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Aprepitant

Brand Name :

Dosage Form : Hard Capsule

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

06

arrow
Immuno-Oncology 360
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Aprepitant

Brand Name :

Dosage Form : Hard Capsule

Dosage Strength : 125MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

07

arrow
Immuno-Oncology 360
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Aprepitant

Brand Name :

Dosage Form : Hard Capsule

Dosage Strength : 165MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

08

arrow
Immuno-Oncology 360
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : USA

Registration Country : Greece

Aprepitant

Brand Name :

Dosage Form : Injectable Emulsion, For Intravenous Use

Dosage Strength : 130MG

Packaging : Single Dose Vial

Approval Date :

Application Number :

Regulatory Info : USA

Registration Country : Greece

Pharmathen

09

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 130MG/18ML (7.2MG/ML)

Packaging :

Approval Date :

Application Number : 218754

Regulatory Info :

Registration Country : USA

blank

10

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : CINVANTI

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 130MG/18ML (7.2MG/ML)

Packaging :

Approval Date : 2017-11-09

Application Number : 209296

Regulatory Info : RX

Registration Country : USA

blank

11

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APONVIE

Dosage Form : EMULSION;INTRAVENOUS

Dosage Strength : 32MG/4.4ML (7.2MG/ML)

Packaging :

Approval Date : 2022-09-16

Application Number : 216457

Regulatory Info : RX

Registration Country : USA

blank

12

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : EMEND

Dosage Form : CAPSULE;ORAL

Dosage Strength : 80MG

Packaging :

Approval Date : 2003-03-26

Application Number : 21549

Regulatory Info : RX

Registration Country : USA

blank

13

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : EMEND

Dosage Form : CAPSULE;ORAL

Dosage Strength : 125MG

Packaging :

Approval Date : 2003-03-26

Application Number : 21549

Regulatory Info : RX

Registration Country : USA

blank

14

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : EMEND

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2006-06-30

Application Number : 21549

Regulatory Info : DISCN

Registration Country : USA

blank

15

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

aprepitant

Brand Name : EMEND

Dosage Form : HARD CAPSULES

Dosage Strength : 125 MG + 80 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

16

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

aprepitant

Brand Name : EMEND

Dosage Form : HARD CAPSULES

Dosage Strength : 80 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

17

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

aprepitant

Brand Name : EMEND

Dosage Form : HARD CAPSULES

Dosage Strength : 40 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

18

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

aprepitant

Brand Name : EMEND

Dosage Form : HARD CAPSULES

Dosage Strength : 125 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

19

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

aprepitant

Brand Name : EMEND

Dosage Form : POWDER FOR ORAL SUSPENSION

Dosage Strength : 125 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

20

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : EMEND

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 125MG/KIT

Packaging :

Approval Date : 2015-12-17

Application Number : 207865

Regulatory Info : RX

Registration Country : USA

blank

21

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 2012-09-24

Application Number : 90999

Regulatory Info : RX

Registration Country : USA

blank

22

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : CAPSULE;ORAL

Dosage Strength : 80MG

Packaging :

Approval Date : 2012-09-24

Application Number : 90999

Regulatory Info : RX

Registration Country : USA

blank

23

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : CAPSULE;ORAL

Dosage Strength : 125MG

Packaging :

Approval Date : 2012-09-24

Application Number : 90999

Regulatory Info : RX

Registration Country : USA

blank

24

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 2020-10-21

Application Number : 211835

Regulatory Info : RX

Registration Country : USA

blank

25

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : CAPSULE;ORAL

Dosage Strength : 80MG

Packaging :

Approval Date : 2020-10-21

Application Number : 211835

Regulatory Info : RX

Registration Country : USA

blank

26

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : CAPSULE;ORAL

Dosage Strength : 125MG

Packaging :

Approval Date : 2020-10-21

Application Number : 211835

Regulatory Info : RX

Registration Country : USA

blank

27

GLENMARK SPECLT

Country
Immuno-Oncology 360
Not Confirmed
arrow

GLENMARK SPECLT

Country
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 2017-10-12

Application Number : 207777

Regulatory Info : RX

Registration Country : USA

blank

28

GLENMARK SPECLT

Country
Immuno-Oncology 360
Not Confirmed
arrow

GLENMARK SPECLT

Country
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : CAPSULE;ORAL

Dosage Strength : 80MG

Packaging :

Approval Date : 2017-10-12

Application Number : 207777

Regulatory Info : RX

Registration Country : USA

blank

29

GLENMARK SPECLT

Country
Immuno-Oncology 360
Not Confirmed
arrow

GLENMARK SPECLT

Country
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : CAPSULE;ORAL

Dosage Strength : 125MG

Packaging :

Approval Date : 2017-10-12

Application Number : 207777

Regulatory Info : RX

Registration Country : USA

blank

30

MYLAN PHARMACEUTICALS INC

Country
Immuno-Oncology 360
Not Confirmed
arrow

MYLAN PHARMACEUTICALS INC

Country
arrow
Immuno-Oncology 360
Not Confirmed

APREPITANT

Brand Name : APREPITANT

Dosage Form : INJECTION, EMULSION

Dosage Strength : 130MG/18ML

Packaging :

Approval Date :

Application Number : 216976

Regulatory Info :

Registration Country : USA

blank